Literature DB >> 22011932

Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

Vik Khullar1.   

Abstract

Overactive bladder (OAB) is highly prevalent and associated with considerable impact on patient health-related quality of life (HRQoL). Assessment of HRQoL can reveal the burden of disease and post-intervention improvement. This review aims to highlight the importance of HRQoL assessment and outline the tools available for use in clinical trials and real-world clinical practice. A number of validated measures of HRQoL specific to OAB have been developed, offering greater sensitivity and responsiveness over generic instruments. These condition-specific, multi-dimensional and single-item global questionnaires are particularly useful for the multiple and varied symptoms of OAB, as they reflect the patient's needs, concerns and values. Measurements for lower urinary tract symptoms, e.g. bladder diaries, are being compared with HRQoL instruments to provide greater understanding of the disease and treatment from the patient's perspective. Therapeutic interventions to improve OAB symptoms should also be evaluated for their effect on the patient's HRQoL.

Entities:  

Mesh:

Year:  2011        PMID: 22011932     DOI: 10.1007/s00192-011-1526-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  83 in total

1.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

2.  Determining the importance of change in the overactive bladder questionnaire.

Authors:  Karin S Coyne; Louis S Matza; Christine L Thompson; Zoe S Kopp; Vikram Khullar
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

Review 3.  Nocturia research: current status and future perspectives.

Authors:  Philip E V Van Kerrebroeck; Roger Dmochowski; Mary P FitzGerald; Hashim Hashim; Jens Peter Norgaard; Dudley Robinson; Jeffrey P Weiss
Journal:  Neurourol Urodyn       Date:  2010-04       Impact factor: 2.696

4.  Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.

Authors:  Alan J Wein; Vik Khullar; Joseph T Wang; Zhonghong Guan
Journal:  BJU Int       Date:  2006-11-28       Impact factor: 5.588

Review 5.  Defining overactive bladder: epidemiology and burden of disease.

Authors:  Andrea Tubaro
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

6.  Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).

Authors:  Louis S Matza; Christine L Thompson; Joel Krasnow; Jessica Brewster-Jordan; Teresa Zyczynski; Karin S Coyne
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

7.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.

Authors:  Karin S Coyne; Chris C Sexton; Debra E Irwin; Zoe S Kopp; Con J Kelleher; Ian Milsom
Journal:  BJU Int       Date:  2008-06       Impact factor: 5.588

8.  Impact of overactive bladder on work productivity in the United States: results from EpiLUTS.

Authors:  Chris C Sexton; Karin S Coyne; Vasudha Vats; Zoe S Kopp; Debra E Irwin; Todd H Wagner
Journal:  Am J Manag Care       Date:  2009-03       Impact factor: 2.229

9.  Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.

Authors:  Norman Zinner; Les Noe; Lawrence Rasouliyan; Thomas Marshall; Raafat Seifeldin
Journal:  Curr Med Res Opin       Date:  2008-04-17       Impact factor: 2.580

10.  Prevalence, evaluation and management of overactive bladder in primary care.

Authors:  Wellman W Cheung; Nadia H Khan; Karmina K Choi; Martin H Bluth; Miriam T Vincent
Journal:  BMC Fam Pract       Date:  2009-01-23       Impact factor: 2.497

View more
  8 in total

Review 1.  A systematic review of English language patient-reported outcome measures for use in urogynaecology and female pelvic medicine.

Authors:  Thomas G Gray; Holly Vickers; Priyanka Krishnaswamy; Swati Jha
Journal:  Int Urogynecol J       Date:  2021-05-26       Impact factor: 2.894

2.  Enhancing Pelvic Health: Optimizing the Services Provided by Primary Health Care Teams in Ontario by Integrating Physiotherapists.

Authors:  Sinéad Dufour; Amy Hondronicols; Kathryn Flanigan
Journal:  Physiother Can       Date:  2019       Impact factor: 1.037

3.  Overactive bladder after female genital mutilation/cutting (FGM/C) type III.

Authors:  Jasmine Abdulcadir; Patrick Dällenbach
Journal:  BMJ Case Rep       Date:  2013-10-04

4.  Depressive symptoms and treatment of women with urgency urinary incontinence.

Authors:  Rachel Kafri; Arad Kodesh; Jeffrey Shames; Jacob Golomb; Itshak Melzer
Journal:  Int Urogynecol J       Date:  2013-05-15       Impact factor: 2.894

5.  The Effects of Suburethral Tape on the Symptoms of Overactive Bladder.

Authors:  G Hensel; M Koštál; J Göbel
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01-21       Impact factor: 2.915

6.  The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials.

Authors:  D Castro-Diaz; C R Chapple; Z Hakimi; M B Blauwet; L Delgado-Herrera; W Lau; S Mujais
Journal:  Qual Life Res       Date:  2015-02-17       Impact factor: 4.147

7.  Development of a core set of outcome measures for OAB treatment.

Authors:  Caroline Foust-Wright; Stephanie Wissig; Caleb Stowell; Elizabeth Olson; Anita Anderson; Jennifer Anger; Linda Cardozo; Nikki Cotterill; Elizabeth Ann Gormley; Philip Toozs-Hobson; John Heesakkers; Peter Herbison; Kate Moore; Jessica McKinney; Abraham Morse; Samantha Pulliam; George Szonyi; Adrian Wagg; Ian Milsom
Journal:  Int Urogynecol J       Date:  2017-09-25       Impact factor: 2.894

8.  The impact of chronic disease on orphans' quality of life living in extended social care services: a cross sectional analysis.

Authors:  Wadi B Alonazi
Journal:  Health Qual Life Outcomes       Date:  2016-04-05       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.